Evolution and Treatments of Chronic Inflammatory Systemic Diseases: Implementation of a Hospital Cohort in Gastroenterology, Dermatology, and Rheumatology Departments at University Hospital of Besanon

What this Trial Is About

Researchers are studying patients with chronic inflammatory diseases (CID) that affect the gut, skin, and joints. These include inflammatory bowel diseases like Crohn's disease and ulcerative colitis, chronic inflammatory skin conditions such as psoriasis and Verneuil's disease, and rheumatic diseases including rheumatoid arthritis, spondyloarthritis, and psoriatic arthritis. The study aims to explore how often patients with one inflammatory disease develop a second related disease and to better understand their evolution and treatment over time. Currently, no common database exists in France for these chronic systemic inflammatory diseases. This observational study follows patients treated at the University Hospital of Besanon in gastroenterology, dermatology, and rheumatology departments. Participants include those diagnosed with inflammatory bowel disease, chronic inflammatory rheumatic disease, or chronic inflammatory skin diseases, meeting specific diagnostic criteria for each condition. The study collects and monitors patient data over a period of up to 10 years to track the diagnosis of additional inflammatory diseases. Participants will be regularly assessed through their ongoing clinical care in the hospital departments. Researchers will collect information on any new inflammatory conditions diagnosed during the study period. The main outcome measured is the occurrence of a second inflammatory disease up to 10 years after enrollment. This long-term observational approach allows monitoring of disease progression and treatment outcomes in a real-world hospital setting.

Evolution and Treatments of Chronic Inflammatory Systemic Diseases